Clinical Trial Update: Phase I Clinical Trial of Autologous CD7-CAR T Cell Therapy for High-risk Acute T-cell Leukemia/lymphoma [Phase 1]

View source ↗

Summary

Phase I trial update for autologous CD7-CAR T cell therapy in high-risk acute T-cell leukemia/lymphoma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoma

Drugs mentioned

• CD7 CAR-T cell therapy

Snippet

Sponsor: Beijing Boren Hospital | Conditions: T Cell Lymphoma, T-cell Leukemia | Phase 1 | Status: COMPLETED